Free Trial
→ The 1934 playbook (From American Alternative) (Ad)tc pixel Free SXTPW Stock Alerts

60 Degrees Pharmaceuticals (SXTPW) Competitors

60 Degrees Pharmaceuticals logo
$0.04 0.00 (-2.59%)
As of 09:42 AM Eastern
Compare

SXTPW vs. DRTSW, APLMW, BIVIW, CDIOW, and CELUW

Should you buy 60 Degrees Pharmaceuticals stock or one of its competitors? MarketBeat compares 60 Degrees Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with 60 Degrees Pharmaceuticals include Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), Cardio Diagnostics (CDIOW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

How does 60 Degrees Pharmaceuticals compare to Alpha Tau Medical?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, media sentiment, dividends, valuation, risk, profitability and institutional ownership.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals and 60 Degrees Pharmaceuticals both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
Alpha Tau Medical Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Apollomics?

Apollomics (NASDAQ:APLMW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

In the previous week, Apollomics had 1 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 2 mentions for Apollomics and 1 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 beat Apollomics' score of 0.43 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Apollomics Neutral
60 Degrees Pharmaceuticals Very Positive

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Summary

Apollomics beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to BioVie?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, media sentiment, analyst recommendations, risk and dividends.

In the previous week, 60 Degrees Pharmaceuticals and 60 Degrees Pharmaceuticals both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
BioVie Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
BioVie N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats BioVie on 1 of the 1 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, dividends, profitability, valuation, media sentiment and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, Cardio Diagnostics and Cardio Diagnostics both had 1 articles in the media. Cardio Diagnostics' average media sentiment score of 1.89 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Cardio Diagnostics Very Positive
60 Degrees Pharmaceuticals Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

How does 60 Degrees Pharmaceuticals compare to Celularity?

Celularity (NASDAQ:CELUW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, valuation, dividends, institutional ownership and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Celularity$26.55MN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
CelularityN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

In the previous week, Celularity had 2 more articles in the media than 60 Degrees Pharmaceuticals. MarketBeat recorded 3 mentions for Celularity and 1 mentions for 60 Degrees Pharmaceuticals. 60 Degrees Pharmaceuticals' average media sentiment score of 1.89 beat Celularity's score of 0.75 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the news media.

Company Overall Sentiment
Celularity Positive
60 Degrees Pharmaceuticals Very Positive

Summary

Celularity beats 60 Degrees Pharmaceuticals on 2 of the 3 factors compared between the two stocks.

Get 60 Degrees Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for SXTPW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SXTPW vs. The Competition

Export
Metric60 Degrees PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$454.79M$6.50B$12.37B
Dividend YieldN/A3.88%2.67%5.66%
P/E RatioN/A3.1724.0124.71
Price / SalesN/A6,488.68540.55165.59
Price / CashN/A13.1327.4837.92
Price / BookN/A88.0210.556.85
Net IncomeN/A-$96.07M$3.56B$337.45M
7 Day PerformanceN/A0.64%1.54%2.70%
1 Month PerformanceN/A0.38%2.48%4.60%
1 Year PerformanceN/A58.74%26.49%32.81%

60 Degrees Pharmaceuticals Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
-2.6%		N/AN/A$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$2.00
flat		N/A+773.3%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
+13.0%		N/A-9.7%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.30
+20.3%		N/AN/A$0.00N/AN/AN/A
CDIOW
Cardio Diagnostics
N/A$0.02
+33.3%		N/A+23.3%$0.00$16.57KN/A7

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SXTPW) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel